The US Food and Drug Administration (FDA) has identified a potential path forward for elamipretide for the treatment of Barth ...

The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

US biotech iTeos Therapeutics (Nasdaq: ITOS) is preparing to wind down its operations and halt clinical work, as it looks to ...

Clinigen has entered a new phase of collaboration with Japanese drugmaker Shionogi (TYO: 4507), signing a licensing agreement ...

Japan’s Daiichi Sankyo (TYO: 4568) and partner Merck & Co (NYSE: MRK) today revealed that the Biologics License Application ...

Japan’s Intellectual Property High Court has ordered Sawai Pharmaceutical (TYO: 4887) and Fuso Pharmaceutical Industries (TYO ...

US biotech Moderna (Nasdaq: MRNA) has reported encouraging early-stage results from a trial of its experimental vaccine for ...

Health and Human Services Secretary Robert F Kennedy Jr has said he may prohibit researchers at government institutions from ...

In the run up to the 2025 annual ASCO meeting, IMUNON (Nasdaq: IMNN) is moving into a Phase III trial with its lead candidate ...

US biotech Hillstar Bio has appointed Maude Tessier as chief operating officer and Shiva Krupa as vice president of program management, reinforcing its leadership bench ahead of a planned clinical ...

Spero Therapeutics (Nasdaq: SPRO) is making headlines as its stock experienced a remarkable 244% surge to $2.35 yesterday, on news of positive clinical trial results.

Artificial Intelligence (AI) has rapidly evolved from a promising technology to a core enabler of innovation in the pharmaceutical industry. Today, AI is estimated to generate between $350 billion and ...